• West Pharmaceutical Services average return on tangible equity for 2024 was 19.91, a 7.4% decline from 2023.
• West Pharmaceutical Services average return on tangible equity for 2023 was 21.5, a 26.52% decline from 2022.
• West Pharmaceutical Services average return on tangible equity for 2022 was 29.26, a 5.03% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.